Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
Safa
Gilles
G
Department of Dermatology, Centre Hospitalier de Saint-Brieuc. gilles.safa@ch-stbrieuc.fr
Loppin
Marion
M
Bousser
Anne-Marie
AM
Barbarot
Sebastien
S
D002648:Child; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept